Pharmaceutical R and D: Costs, Risks and Rewards

0 avg rating
( 0 ratings by Goodreads )
 
9781410220493: Pharmaceutical R and D: Costs, Risks and Rewards

Pharmaceutical costs are among the fastest growing components of health care costs today. Although increases in the inflation-adjusted prices of ethical drugs and perceived high prices of new drugs have been a concern of congressional committees for over 30 years, the growing Federal role in paying for prescription drugs has increased the concern over the appropriateness of prices relative to the costs of bringing new drugs to market. Specific policies of U.S. and other governments can alter the delicate balance between costs and returns to pharmaceutical R&D, with ramifications for the future health of Americans, for health care costs, and for the future of the U.S. pharmaceutical industry. OTA's report focuses mainly on the economic side of the R&D process. Pharmaceutical R&D is an investment, and the principal characteristic of an investment is that money is spent today in the hopes of generating even more money in the future. Pharmaceutical R&D is a risky investment; therefore, high financial returns are necessary to induce companies to invest in researching new chemical entities. Changes in Federal policy that affect the cost, uncertainty and returns of pharmaceutical R&D may have dramatic effects on the investment patterns of the industry. Given this sensitivity to policy changes, careful consideration of the effects on R&D is needed. The specific request for this study came from the House Committee on Energy and Commerce and its Subcommittee on Health and the Environment. The Senate Committee on the Judiciary's Subcommittee on Antitrust, Monopolies, and Business Rights endorsed the study. OTA was assisted in this study by an advisory panel of business, consumer, and academic leaders chaired by Frederick M. Scherer, Ph.D., Professor of Economics, John E Kennedy School of Government at Harvard University. OTA gratefully acknowledges the contribution of each of these individuals. As with all OTA reports, the final responsibility for the content of the assessment rests with OTA.

"synopsis" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Office of Technology Assessment
Published by University Press of the Pacific (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description University Press of the Pacific, 2005. PAP. Book Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 29.35
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

2.

Office of Technology Assessment
Published by University Press of the Pacific 2005-02 (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Quantity Available: 5
Print on Demand
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description University Press of the Pacific 2005-02, 2005. Book Condition: New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bookseller Inventory # NU-LSI-06920879

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 32.23
Convert Currency

Add to Basket

Shipping: US$ 3.99
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Office of Technology Assessment
Published by University Press of the Pacific, United States (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description University Press of the Pacific, United States, 2005. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****. Pharmaceutical costs are among the fastest growing components of health care costs today. Although increases in the inflation-adjusted prices of ethical drugs and perceived high prices of new drugs have been a concern of congressional committees for over 30 years, the growing Federal role in paying for prescription drugs has increased the concern over the appropriateness of prices relative to the costs of bringing new drugs to market. Specific policies of U.S. and other governments can alter the delicate balance between costs and returns to pharmaceutical RD, with ramifications for the future health of Americans, for health care costs, and for the future of the U.S. pharmaceutical industry. OTA s report focuses mainly on the economic side of the RD process. Pharmaceutical RD is an investment, and the principal characteristic of an investment is that money is spent today in the hopes of generating even more money in the future. Pharmaceutical RD is a risky investment; therefore, high financial returns are necessary to induce companies to invest in researching new chemical entities. Changes in Federal policy that affect the cost, uncertainty and returns of pharmaceutical RD may have dramatic effects on the investment patterns of the industry. Given this sensitivity to policy changes, careful consideration of the effects on RD is needed. The specific request for this study came from the House Committee on Energy and Commerce and its Subcommittee on Health and the Environment. The Senate Committee on the Judiciary s Subcommittee on Antitrust, Monopolies, and Business Rights endorsed the study. OTA was assisted in this study by an advisory panel of business, consumer, and academicleaders chaired by Frederick M. Scherer, Ph.D., Professor of Economics, John E Kennedy School of Government at Harvard University. OTA gratefully acknowledges the contribution of each of these individuals. As with all OTA reports, the final responsibility for the content of the assessment rests with OTA. Bookseller Inventory # AAV9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 40.66
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Office of Technology Assessment
Published by University Press of the Pacific, United States (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description University Press of the Pacific, United States, 2005. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****.Pharmaceutical costs are among the fastest growing components of health care costs today. Although increases in the inflation-adjusted prices of ethical drugs and perceived high prices of new drugs have been a concern of congressional committees for over 30 years, the growing Federal role in paying for prescription drugs has increased the concern over the appropriateness of prices relative to the costs of bringing new drugs to market. Specific policies of U.S. and other governments can alter the delicate balance between costs and returns to pharmaceutical RD, with ramifications for the future health of Americans, for health care costs, and for the future of the U.S. pharmaceutical industry. OTA s report focuses mainly on the economic side of the RD process. Pharmaceutical RD is an investment, and the principal characteristic of an investment is that money is spent today in the hopes of generating even more money in the future. Pharmaceutical RD is a risky investment; therefore, high financial returns are necessary to induce companies to invest in researching new chemical entities. Changes in Federal policy that affect the cost, uncertainty and returns of pharmaceutical RD may have dramatic effects on the investment patterns of the industry. Given this sensitivity to policy changes, careful consideration of the effects on RD is needed. The specific request for this study came from the House Committee on Energy and Commerce and its Subcommittee on Health and the Environment. The Senate Committee on the Judiciary s Subcommittee on Antitrust, Monopolies, and Business Rights endorsed the study. OTA was assisted in this study by an advisory panel of business, consumer, and academicleaders chaired by Frederick M. Scherer, Ph.D., Professor of Economics, John E Kennedy School of Government at Harvard University. OTA gratefully acknowledges the contribution of each of these individuals. As with all OTA reports, the final responsibility for the content of the assessment rests with OTA. Bookseller Inventory # AAV9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 41.62
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Office of Technology Assessment
Published by University Press of the Pacific (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description University Press of the Pacific, 2005. PAP. Book Condition: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 31.53
Convert Currency

Add to Basket

Shipping: US$ 12.00
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Office of Technology Assessment
Published by University Press of the Pacific (2016)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description University Press of the Pacific, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9781410220493_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 40.54
Convert Currency

Add to Basket

Shipping: US$ 5.16
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Office Of Technology Assessment
Published by University Press of the Pacific
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Paperback Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description University Press of the Pacific. Paperback. Book Condition: New. 368 pages. Dimensions: 10.9in. x 8.1in. x 0.9in.Pharmaceutical costs are among the fastest growing components of health care costs today. Although increases in the inflation-adjusted prices of ethical drugs and perceived high prices of new drugs have been a concern of congressional committees for over 30 years, the growing Federal role in paying for prescription drugs has increased the concern over the appropriateness of prices relative to the costs of bringing new drugs to market. Specific policies of U. S. and other governments can alter the delicate balance between costs and returns to pharmaceutical R and D, with ramifications for the future health of Americans, for health care costs, and for the future of the U. S. pharmaceutical industry. OTAs report focuses mainly on the economic side of the R and D process. Pharmaceutical R and D is an investment, and the principal characteristic of an investment is that money is spent today in the hopes of generating even more money in the future. Pharmaceutical R and D is a risky investment; therefore, high financial returns are necessary to induce companies to invest in researching new chemical entities. Changes in Federal policy that affect the cost, uncertainty and returns of pharmaceutical R and D may have dramatic effects on the investment patterns of the industry. Given this sensitivity to policy changes, careful consideration of the effects on R and D is needed. The specific request for this study came from the House Committee on Energy and Commerce and its Subcommittee on Health and the Environment. The Senate Committee on the Judiciarys Subcommittee on Antitrust, Monopolies, and Business Rights endorsed the study. OTA was assisted in this study by an advisory panel of business, consumer, and academic leaders chaired by Frederick M. Scherer, Ph. D. , Professor of Economics, John E Kennedy School of Government at Harvard University. OTA gratefully acknowledges the contribution of each of these individuals. As with all OTA reports, the final responsibility for the content of the assessment rests with OTA. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Bookseller Inventory # 9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 49.96
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

8.

Assessment, Office of Technology
Published by University Press of the Pacific
ISBN 10: 1410220494 ISBN 13: 9781410220493
New PAPERBACK Quantity Available: > 20
Seller:
Russell Books
(Victoria, BC, Canada)
Rating
[?]

Book Description University Press of the Pacific. PAPERBACK. Book Condition: New. 1410220494 Special order direct from the distributor. Bookseller Inventory # ING9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 44.25
Convert Currency

Add to Basket

Shipping: US$ 7.00
From Canada to U.S.A.
Destination, Rates & Speeds

9.

Office of Technology Assessment
Published by University Press of the Pacific (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Softcover Quantity Available: 1
Print on Demand
Seller:
Rating
[?]

Book Description University Press of the Pacific, 2005. Book Condition: New. This item is printed on demand for shipment within 3 working days. Bookseller Inventory # GM9781410220493

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 49.89
Convert Currency

Add to Basket

Shipping: US$ 3.51
From Germany to U.S.A.
Destination, Rates & Speeds

10.

Office of Technology Assessment
Published by University Press of the Pacific (2005)
ISBN 10: 1410220494 ISBN 13: 9781410220493
New Paperback Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description University Press of the Pacific, 2005. Paperback. Book Condition: New. book. Bookseller Inventory # M1410220494

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 65.94
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book